Macquarie Group
IGMS

Macquarie Group’s IGM Biosciences IGMS Stock Holding History

Macquarie Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,342
Closed -$20 – 1751
2024
Q4 		$20 Buy
+3,342
New +$39.7K ﹤0.01% 1656
2022
Q3 		– Sell
-579
Closed -$11.7K – 2311
2022
Q2 		$10K Hold
579
– – ﹤0.01% 2443
2022
Q1 		$15 Hold
579
– – ﹤0.01% 2447
2021
Q4 		$17K Hold
579
– – ﹤0.01% 2432
2021
Q3 		$38K Hold
579
– – ﹤0.01% 2310
2021
Q2 		$48K Buy
579
+439
+314% +$32.5K ﹤0.01% 2169
2021
Q1 		$11K Sell
140
-66
-32% -$6.01K ﹤0.01% 2379
2020
Q4 		$18K Hold
206
– – ﹤0.01% 2241
2020
Q3 		$15K Hold
206
– – ﹤0.01% 2221
2020
Q2 		$15K Buy
+206
New +$12.5K ﹤0.01% 2231

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Macquarie Group's IGMS Position: Q1 2025 in Review

Macquarie Group sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 3,342 shares — an estimated $20 sold.

Macquarie Group first reported a position in IGMS in Q2 2020 and held it in 10 quarters. The position peaked at $48K in Q2 2021. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Macquarie Group reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Macquarie Group sold 3,342 IGM Biosciences shares in Q1 2025, an estimated $20.
  • Macquarie Group first reported a position in IGM Biosciences in Q2 2020 and held it in 10 quarters.
  • Macquarie Group's IGM Biosciences position peaked at $48K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Macquarie Group's 13F filing for Q1 2025, filed 15 May 2025.